* Viveve Medical Inc VIVE.OQ VIVE.O is expected to show
a fall
in quarterly revenue when it reports results on March 17.
* The Englewood Colorado-based company is expected to
report a
12.4% decrease in revenue to $1.705 million from $1.95 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Viveve Medical Inc
is for
a loss of 59 cents per share. For the same quarter last year,
the company reported a loss of $1.85 per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Viveve
Medical
Inc is $9.63, above its last closing price of $0.80.
This summary was machine generated March 15 at 20:28 GMT. All
figures in US dollars unless otherwise stated